Varian to Acquire InfiMed for $15M

Lena Kauffman | | Radiology Business | Business Intelligence
The corporate consolidation beat marches on this week, as Varian Medical Systems scooped up digital radiography and fluoroscopy vendor InfiMed for $15 million plus “earnouts based on sales of InfiMed products achieved over the next 24 months,” according to a press release. Although the deal is not expected to be finalized until next month, it marks another verse in the familiar tune of business acquisitions of all kinds within the imaging industry, whether to private equity groups or larger vendors. The 60-person, Syracuse, NY-based InfiMed develops digital medical imaging systems for fluoroscopy, angiography, cardiology, and general radiography. Varian X-Ray Products president Robert Kluge said in an announcement that the deal will better enable Varian to become “a one-stop shop for x-ray tubes, flat panel image detectors, and workstations.” In the same release, InfiMed president Amy Ryan said that InfiMed would receive greater visibility of its technology profile through the agreement. “By joining with Varian, we will be able to offer our leading technology in digital image processing to more customers around the world,” Ryan’s statement read.

Lena Kauffman,

Contributor

Lena Kauffman is a contributing writer based in Ann Arbor, Michigan.

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.